Weinsaft Jonathan W, Cham Matthew D, Janik Matthew, Min James K, Henschke Claudia I, Yankelevitz David F, Devereux Richard B
Greenberg Division of Cardiology, Department of Medicine, New York Presbyterian Hospital - Weill Cornell Medical Center, New York, NY 10021, USA.
Int J Cardiol. 2008 Jun 6;126(3):359-65. doi: 10.1016/j.ijcard.2007.04.179. Epub 2007 Aug 14.
Left ventricular (LV) mass and ejection fraction are of diagnostic and therapeutic importance in patients with systolic dysfunction. Cardiac MRI (CMR) has been proposed as a standard for these indices. Prior studies have variably included papillary muscles and trabeculae in either intracavitary or myocardial volumes. Quantitative effects and clinical implications of this methodological difference in patients with systolic dysfunction are unknown.
Fifty consecutive patients with known systolic dysfunction (EF<40%) underwent CMR. LV volumes were determined using previously established methods: Method 1 included papillary muscles and trabeculae in cavity volume, method 2 included these in myocardial volume. Both methods were used for each patient with tracings superimposed to isolate papillary/trabecular volume and insure consistency of other endocardial contours. Readers applied methods in random order blinded to clinical findings and results of the other method.
LV mass differed substantially by method (p<0.001) with absolute difference of 16.6%. Ejection fraction differed by 3 points (p<0.001) with absolute differences of > or =5 points in 16% of patients. Mean differences in LV mass and ejection fraction were produced by consistent methodological differences on a per-patient basis. Methodology used produced differences in patients meeting established criteria for LV hypertrophy (28% vs. 60%, p<0.001) and ICD implantation (64% vs. 48%, p<0.01).
LV mass and ejection fraction differ significantly between commonly employed CMR methods. Alternative inclusion of papillary muscles and trabeculae in either cavity or myocardial volumes produces significant differences in clinical and therapeutic indices that can affect management of patients with advanced systolic dysfunction.
左心室(LV)质量和射血分数对收缩功能障碍患者的诊断和治疗具有重要意义。心脏磁共振成像(CMR)已被提议作为这些指标的标准。先前的研究在确定心腔内或心肌体积时,对乳头肌和小梁的纳入方式各不相同。这种方法学差异对收缩功能障碍患者的定量影响和临床意义尚不清楚。
连续50例已知收缩功能障碍(EF<40%)的患者接受了CMR检查。左心室容积采用先前确立的方法测定:方法1将乳头肌和小梁纳入心腔容积,方法2将其纳入心肌容积。对每位患者都使用这两种方法,并叠加描记以分离乳头肌/小梁容积,确保其他心内膜轮廓的一致性。阅片者以随机顺序应用这两种方法,对临床发现和另一种方法的结果不知情。
不同方法测得的左心室质量有显著差异(p<0.001),绝对差异为16.6%。射血分数相差3个百分点(p<0.001),16%的患者绝对差异≥5个百分点。左心室质量和射血分数的平均差异是由每位患者方法上的一致差异产生的。所采用的方法在符合左心室肥厚既定标准的患者(28%对60%,p<0.001)和植入ICD的患者(64%对48%,p<0.01)中产生了差异。
常用的CMR方法之间,左心室质量和射血分数存在显著差异。在腔室或心肌容积中对乳头肌和小梁的不同纳入方式,会在临床和治疗指标上产生显著差异,这可能会影响晚期收缩功能障碍患者的管理。